XZ4-11891-84724
4 vaccinations
8 coded responses
36 check-ins
7 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 076 / NJ
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-07
- 2021-04-14
-
2021-04-21
Survey response — 14 day, dose 2MedDRA: Feeling abnormal, Headache, Tenderness — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-04-28
- 2021-05-05
-
2021-05-12
Survey response — 35 day, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-19
- 2021-07-07
- 2021-10-06
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2022-04-07
-
2022-05-12
Survey response — 6 month, dose 3MedDRA: Brain fog, Chills, Oropharyngeal pain, SARS-CoV-2 test positive, Upper-airway cough syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-06-18
Dose 4 — Pfizer-BioNTech
- 2022-06-18
- 2022-06-19
- 2022-06-20
-
2022-06-21
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · DiarrheaAdult check-in
-
2022-06-22
Survey response — days 1–6 daily, dose 4MedDRA: Cough, SARS-CoV-2 test positive — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-06-23
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-06-24
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2022-06-25
- 2022-07-02
- 2022-07-09
- 2022-07-16
- 2022-07-23
- 2022-07-30
- 2022-09-17
-
2022-12-17
Survey response — 6 month, dose 4MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2023-06-18
Survey response — 12 month, dose 4MedDRA: Exposure to SARS-CoV-2, Impaired work ability, Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-06-18 | Pfizer-BioNTech | No |
Free text
Release 7
Symptoms: My head is sensitive to touch and occasionally throbs near the surface. This started last night and has continued through today.My head was somewhat fuzzy this morning.
Release 8
Symptoms: Ive had a slight sore throat for the past week.
Release 11
Symptoms: Chills, fogginess, slight sore throat with some post nasal drip. Test positive for COVID with an at-home test on 5/11/2022.
Release 12
Systemic reaction (other): Not related to the vaccine: I have had a persistent cough since testing positive for COVID-19 in early May.
Systemic reaction (other): Still coughing, post-Covid
Systemic reaction (other): Still have a post-Covid cough.
Symptoms: Cold symptoms - cough, runny nose for the past month
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Tenderness | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release